Inventor · disambiguated record
Yukihiro Nishio
Also filed as: NISHIO YUKIHIRO
9 granted patents·3 pending applications·36 citations·filing 2009–2020
83Inventor score
Files withSUMITOMO DAINIPPON PHARMA CO LTD6TORAY INDUSTRIES3SUMITOMO PHARMA CO LTD2DAINIPPON SUMITOMO PHARMA CO1
Top patents by PatentIndex Score
12 records- 0193US9248173B2WT1 antigen peptide conjugate vaccineSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2015·Granted Feb 2, 2016·14 cites·28 claims
- 0292US9181302B2WT1 antigen peptide conjugate vaccineSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2014·Granted Nov 10, 2015·17 cites·21 claims
- 0388US11759509B2WT1 antigen peptide conjugate vaccineSUMITOMO PHARMA CO LTD·Filed 2018·Granted Sep 19, 2023·2 cites·13 claims
- 0473US10588952B2Conjugate vaccine using trimming function of ERAP1SUMITOMO DAINIPPON PHARMA CO LTD·Filed 2014·Granted Mar 17, 2020·2 cites·8 claims
- 0565US10280145B2Urea derivative and use thereforTORAY INDUSTRIES·Filed 2016·Granted May 7, 2019·1 cites·8 claims
- 0658US2020171136A1Conjugate vaccine using trimming function of erap1SUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 0753US2016114019A1Wt1 antigen peptide conjugate vaccineSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2015·Application pending·0 cites
- 0850US12018093B2Hemiasterlin derivatives and antibody-drug conjugates including sameSUMITOMO PHARMA CO LTD·Filed 2018·Granted Jun 25, 2024·0 cites·25 claims
- 0950US2011009433A1Bicyclic pyrrole compoundDAINIPPON SUMITOMO PHARMA CO·Filed 2009·Application pending·0 cites
- 1044US10519106B2Urea derivative and use thereforTORAY INDUSTRIES·Filed 2016·Granted Dec 31, 2019·0 cites·8 claims
- 1136US10792365B2Peptide derivative and use thereofTORAY INDUSTRIES·Filed 2017·Granted Oct 6, 2020·0 cites·19 claims
- 1235US10597397B2Adenine conjugate compounds and their use as vaccine adjuvantsSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2016·Granted Mar 24, 2020·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Yukihiro Nishio files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →